Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00834652 · ClinicalTrials.gov registry record · Phase 4
Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 206
- Enrollment target
NCT00834652 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 206 participants.
The verdict
NCT00834652, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 206 participants
- Enrollment target
Study Summary
This study will determine whether the drug metformin improves the effects of traditional antidepressant medications in people who are overweight.
Interventions
- DRUG Metformin
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00834652
The ClinicalTrials.gov registry entry for NCT00834652 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT00834652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00834652 about?
NCT00834652 is a clinical study titled "Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight". This study will determine whether the drug metformin improves the effects of traditional antidepressant medications in people who are overweight.
What is the current status of trial NCT00834652?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 206 participants. The study started on 2007-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00834652?
The interventions under investigation include: Metformin (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT00834652?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.